|
BRGX BioRegenx Inc 1593184 |
| Balance Sheet |
|
Current Assets
|
$190,292.00 |
|
Assets
|
$337,070.00 |
|
Current Liabilities
|
$3,987,822.00 |
|
Liabilities
|
$4,870,386.00 |
|
Equity
|
$-4,533,316.00 |
|
Shares Out
|
971575183.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$26,629.00 |
|
Investing Cash Flow
|
$-59,057.00 |
| Market Analysis |
Market Cap
|
$9,715,751.83 |
|
Price
|
$0.01 |
|
PB
|
0.46 |
|
PS
|
5.70 |
|
FCF
|
$17,572.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:46 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BRGX documents filed with the SEC.
BRGX Filings
Clear
